Thomas Olin
Chief Tech/Sci/R&D Officer at KANCERA AB
Profile
Thomas Olin is currently the Chief Executive Officer at iNovacia AB since 2006.
He is also a Director at Blasieholmen Investment Group AB.
In addition, he holds the position of Chief Scientific Officer & Executive VP at Kancera AB since 2010.
Previously, he served as the Chief Executive Officer & Director at SaltX Technology Holding AB.
He also worked as an Independent Director at Klaria Pharma Holding AB.
Prior to that, he was a Project Leader & Senior Researcher at Pharmacia & Upjohn, Inc. and an Area Manager-Nutrition Research at Pharmacia Hospital Care.
Thomas Olin active positions
| Companies | Position | Start |
|---|---|---|
| KANCERA AB | Chief Tech/Sci/R&D Officer | 01/07/2023 |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Chief Executive Officer | 01/01/2006 |
| Blasieholmen Investment Group AB | Director/Board Member | - |
Former positions of Thomas Olin
| Companies | Position | End |
|---|---|---|
| KLARIA PHARMA HOLDING AB | Director/Board Member | - |
| Pharmacia Hospital Care | Corporate Officer/Principal | - |
| SALTX TECHNOLOGY HOLDING AB | Chief Executive Officer | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KANCERA AB | Health Technology |
| SALTX TECHNOLOGY HOLDING AB | Electronic Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Private companies | 4 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
| Pharmacia Hospital Care | |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
| Blasieholmen Investment Group AB |
- Stock Market
- Insiders
- Thomas Olin
